JOHN KIM
Allopathic & Osteopathic Physicians|Internal Medicine DALLAS, TX NPI 1194388736
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine TX BeiGene USA, Inc. All categories
General Payments — all program years on this page
$4,992.60
- Category: General Payments
- Program years: PY2022–2024
- Record count: 79
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $3,615.48 across 36 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,750.00 | 1 |
| Food and Beverage | $695.54 | 33 |
| Education | $169.94 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| BeiGene USA, Inc. | $2,750.00 | 1 |
| Incyte Corporation | $177.91 | 7 |
| SANOFI-AVENTIS U.S. LLC | $99.95 | 1 |
| Merck Sharp & Dohme Corporation | $68.53 | 3 |
| GENZYME CORPORATION | $58.59 | 2 |
| SOBI, INC | $53.76 | 2 |
| Rigel Pharmaceuticals, Inc. | $52.79 | 5 |
| ADC Therapeutics America, Inc. | $47.26 | 2 |
| Genmab U.S., Inc. | $45.50 | 2 |
| Janssen Biotech, Inc. | $43.03 | 1 |
| Karyopharm Therapeutics Inc. | $42.58 | 2 |
| Mirati Therapeutics, Inc. | $39.41 | 2 |
| Regeneron Healthcare Solutions, Inc. | $29.90 | 1 |
| Blueprint Medicines Corporation | $27.77 | 1 |
| Lilly USA, LLC | $23.32 | 1 |
| SERVIER PHARMACEUTICALS LLC | $22.14 | 1 |
| GlaxoSmithKline, LLC. | $18.76 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.28 | 1 |
By program year
Records — PY2024 (36)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.